申请人:Thurkauf Andrew
公开号:US20050239799A1
公开(公告)日:2005-10-27
Disclosed are compounds of the formula:
or the pharmaceutically acceptable addition salts thereof wherein:
R
1
is halogen or C
1
-C
4
alkyl; and
R
2
and R
3
are the same or different and represent hydrogen, halogen, C
1
-C
4
alkyl, C
1
-C
4
alkoxy, alkylthio, hydroxy, amino, mono(C
1
-C
4
)alkylamino, di(C
1
-C
4
)alkylamino, or
R
2
and R
3
together represent a 4 carbon alkenylene moiety that together with the phenyl ring to which they are attached form a naphthyl moiety, which compounds are useful in the treatment of neuropsycological diseases such as schizophrenia, psychotic depression and mania.
本发明涉及以下公式的化合物:或其药学上可接受的加成盐,其中:R1是卤素或C1-C4烷基;R2和R3相同或不同,代表氢、卤素、C1-C4烷基、C1-C4烷氧基、烷基硫基、羟基、氨基、单(C1-C4)烷基氨基、双(C1-C4)烷基氨基,或R2和R3共同代表一个4碳烯基单元,与它们所连接的苯环共同形成萘基单元,这些化合物在治疗神经精神疾病,如精神分裂症、精神抑郁症和躁狂症方面有用。